ATPexponering

ATPexponering refers to exposure to extracellular adenosine triphosphate (ATP) in biological systems. It describes the stimulus produced when ATP is present outside cells, either released by stressed or damaged cells or applied in experimental settings. ATP outside the cell functions as a signaling molecule in many tissues and can influence processes such as inflammation, pain perception, vasodilation, and tissue repair.

In physiological conditions, extracellular ATP is generated through cell injury, hypoxia, or regulated release from vesicles. It acts mainly through purinergic receptors, including P2X ligand-gated ion channels and P2Y G-protein-coupled receptors, which trigger diverse signaling cascades such as calcium flux, MAPK activation, and changes in cyclic nucleotides. The effects of ATP exposure depend on concentration, duration, and the repertoire of receptors expressed by the target cells. High local concentrations can activate the P2X7 receptor, potentially leading to pore formation and cell death or the release of inflammatory mediators.

Measurement and experimental considerations involve quantifying ATP levels and controlling exposure conditions. Common methods include luciferase-based bioluminescence assays for ATP detection and using receptor agonists or antagonists to dissect signaling pathways. ATP is rapidly hydrolyzed in the extracellular space by ectonucleotidases such as CD39 and CD73, which can shape the duration and outcome of ATPexponering.

Applications of studying ATPexponering include research into purinergic signaling, inflammation, pain mechanisms, and tissue injury responses. It also informs pharmacological targeting of P2 receptors and the development of diagnostics where extracellular ATP serves as an indicator of tissue stress. See also purinergic signaling, P2X receptors, P2Y receptors, ectonucleotidases.